Bedrosian Camille L
Insider CIK 1326969 · RARE EVP and Chief Medical Officer · RYTM Director · CRNX Director · AMLX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 2,081 | $33.09 | $68.9K | 278,064 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 7,947 | $32.21 | $256.0K | 280,145 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 2,081 | $33.09 | $68.9K | 278,064 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-09-10 | 2026-09-14 | 7,947 | $32.21 | $256.0K | 280,145 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 25,000 | $68.92 | $1.72M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.77 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $66.71 | $1.17M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 16,300 | $85.00 | $1.39M | 5,925 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $66.71 | $1.17M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.77 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 25,000 | $68.92 | $1.72M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 16,300 | $85.00 | $1.39M | 5,925 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-08-18 | 2026-08-20 | 22,807 | — | $0 | 288,092 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-08-18 | 2026-08-20 | 22,807 | — | $0 | 288,092 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-06-18 | 2026-06-22 | 9,730 | — | $0 | 9,730 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-06-18 | 2026-06-22 | 5,925 | — | $0 | 22,225 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 143,985 | — | $0 | 143,985 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2026-03-05 | 2026-03-09 | 95,990 | — | $0 | 265,285 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2026-03-02 | 2026-03-04 | 6,461 | $14.58 | $94.2K | 169,295 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-12-01 | 2025-12-03 | 6,580 | $14.35 | $94.4K | 175,756 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-09-30 | 2025-10-02 | 12,039 | $14.58 | $175.5K | 182,336 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-06-24 | 2025-06-26 | 4,712 | — | $0 | 4,712 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-06-24 | 2025-06-26 | 7,037 | — | $0 | 7,037 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-06-18 | 2025-06-23 | 4,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-06-18 | 2025-06-23 | 4,000 | — | $0 | 7,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-06-11 | 2025-06-13 | 10,350 | — | $0 | 10,350 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-06-11 | 2025-06-13 | 6,900 | — | $0 | 16,300 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2025-03-31 | 2025-04-02 | 12,425 | $3.47 | $43.1K | 194,375 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2025-03-06 | 2025-03-10 | 102,630 | — | $0 | 102,630 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2025-03-06 | 2025-03-10 | 68,420 | — | $0 | 206,800 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-12-02 | 2024-12-03 | 5,421 | $5.54 | $30.0K | 138,380 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2024-09-30 | 2024-10-02 | 11,442 | $3.20 | $36.6K | 143,801 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-06-21 | 2024-06-25 | 3,000 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-06-21 | 2024-06-25 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-06-18 | 2024-06-20 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-06-18 | 2024-06-20 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-06-07 | 2024-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-06-07 | 2024-06-11 | 3,400 | — | $0 | 9,400 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2024-04-16 | 2024-04-18 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2024-04-16 | 2024-04-18 | 96,910 | — | $0 | 155,243 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award deriv | 2023-11-27 | 2023-11-29 | 162,500 | — | $0 | 162,500 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | A Award | 2023-11-27 | 2023-11-29 | 58,333 | — | $0 | 58,333 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-06-16 | 2023-06-21 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-06-16 | 2023-06-21 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-03-01 | 2023-03-03 | 3,881 | $45.25 | $175.6K | 46,720 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-03-01 | 2023-03-03 | 2,663 | — | $0 | 50,601 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-06-17 | 2022-06-21 | 17,500 | — | $0 | 17,500 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2022-06-08 | 2022-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2022-03-01 | 2022-03-03 | 24,900 | — | $0 | 24,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2022-03-01 | 2022-03-03 | 14,000 | — | $0 | 47,938 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-03-01 | 2022-03-03 | 2,821 | $66.62 | $187.9K | 33,938 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-01-30 | 2022-02-01 | 1,657 | $66.30 | $109.9K | 36,759 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-10-14 | 2021-10-18 | 359 | $81.14 | $29.1K | 38,416 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2021-09-02 | 2021-09-02 | 2,500 | — | $0 | 53,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-09-02 | 2021-09-02 | 2,500 | $100.18 | $250.5K | 38,775 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2021-09-02 | 2021-09-02 | 2,500 | $55.00 | $137.5K | 41,275 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2021-09-01 | 2021-09-02 | 2,500 | — | $0 | 55,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-09-01 | 2021-09-02 | 2,500 | $100.03 | $250.1K | 38,775 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2021-09-01 | 2021-09-02 | 2,500 | $55.00 | $137.5K | 41,275 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2021-06-22 | 2021-06-23 | 17,500 | — | $0 | 17,500 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-06-09 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-05-06 | 2021-05-10 | 364 | $113.67 | $41.4K | 38,775 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2021-04-15 | 2021-04-19 | 5,000 | — | $0 | 58,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-04-15 | 2021-04-19 | 5,000 | $109.09 | $545.5K | 39,139 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2021-04-15 | 2021-04-19 | 5,000 | $55.00 | $275.0K | 44,139 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2021-03-01 | 2021-03-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 4,636 | — | $0 | 43,682 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-03-01 | 2021-03-03 | 4,543 | $138.18 | $627.8K | 39,139 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 5,500 | — | $0 | 39,046 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-01-30 | 2021-02-02 | 2,243 | $140.36 | $314.8K | 33,546 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2021-01-15 | 2021-01-19 | 25,000 | — | $0 | 63,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-01-15 | 2021-01-19 | 25,000 | $139.18 | $3.48M | 35,789 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2021-01-15 | 2021-01-19 | 25,000 | $55.00 | $1.38M | 60,789 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-12-09 | 2020-12-11 | 37,000 | — | $0 | 37,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-10-14 | 2020-10-16 | 262 | $88.00 | $23.1K | 35,789 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2020-09-01 | 2020-09-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-05-06 | 2020-05-08 | 249 | $66.26 | $16.5K | 36,051 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2020-03-01 | 2020-03-03 | 21,000 | — | $0 | 21,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-03-01 | 2020-03-03 | 1,249 | $56.08 | $70.0K | 36,300 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 5,634 | — | $0 | 37,549 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 7,300 | — | $0 | 31,915 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-01-30 | 2020-01-31 | 1,624 | $53.23 | $86.4K | 24,615 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-10-14 | 2019-10-16 | 1,437 | — | $0 | 26,239 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-05-06 | 2019-05-07 | 1,438 | — | $0 | 24,802 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-03-01 | 2019-03-04 | 21,500 | — | $0 | 21,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-03-01 | 2019-03-04 | 7,000 | — | $0 | 23,364 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-01-30 | 2019-02-15 | 1,636 | $48.85 | $79.9K | 16,364 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2018-01-30 | 2018-01-31 | 88,000 | — | $0 | 88,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-01-30 | 2018-01-31 | 18,000 | — | $0 | 18,000 | SEC↗ |